Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

CXD101 and nivolumab in patients with metastatic microsatellite-stable colorectal cancer (CAROSELL): a multicentre, open-label, single-arm, phase II trial.

Journal article

Saunders MP. et al, (2022), ESMO Open, 7

A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation study.

Journal article

Kleppe A. et al, (2022), Lancet Oncol

The UK benefits from a truly National Health Service.

Journal article

Barnes E. et al, (2022), Lancet

Cancer in sub-Saharan Africa: a Lancet Oncology Commission.

Journal article

Ngwa W. et al, (2022), Lancet Oncol

The Influence of Activin on the Tumor Microenvironment in Colon Cancer Metastasis.

Journal article

Wiley MB. et al, (2022), FASEB J, 36 Suppl 1

Genetic variation in ST6GAL1 is a determinant of capecitabine and oxaliplatin induced hand-foot syndrome.

Journal article

Watts K. et al, (2022), Int J Cancer

The Essentials of Multiomics.

Journal article

Marshall JL. et al, (2022), Oncologist, 27, 272 - 284

Immune modulation underpins the anti-cancer activity of HDAC inhibitors.

Journal article

Blaszczak W. et al, (2021), Mol Oncol, 15, 3280 - 3298

Personalising cancer medicine with prognostic markers.

Journal article

Kerr DJ. and Yang L., (2021), EBioMedicine, 72

Automated assessment of CD8+ T-lymphocytes and stroma fractions complement conventional staging of colorectal cancer.

Journal article

Jiang D. et al, (2021), EBioMedicine, 71

Novel therapeutic strategies: targeting epithelial-mesenchymal transition in colorectal cancer.

Journal article

Zhang N. et al, (2021), Lancet Oncol, 22, e358 - e368

A Phase 2a cohort expansion study to assess the safety, tolerability, and preliminary efficacy of CXD101 in patients with advanced solid-organ cancer expressing HR23B or lymphoma.

Journal article

Booth SW. et al, (2021), BMC Cancer, 21

Genome-wide association studies of toxicity to oxaliplatin and fluoropyrimidine chemotherapy with or without cetuximab in 1800 patients with advanced colorectal cancer.

Journal article

Watts K. et al, (2021), Int J Cancer

Stromal composition predicts recurrence of early rectal cancer after local excision.

Journal article

Jones HJ. et al, (2021), Histopathology

The clinical features of polymerase proof-reading associated polyposis (PPAP) and recommendations for patient management.

Journal article

Palles C. et al, (2021), Fam Cancer

Celecoxib for Stage III Colon Cancer.

Journal article

Kerr DJ. et al, (2021), JAMA, 325, 1257 - 1258

An Evaluation of the Diagnostic Accuracy of a Panel of Variants in DPYD and a Single Variant in ENOSF1 for Predicting Common Capecitabine Related Toxicities.

Journal article

Palles C. et al, (2021), Cancers (Basel), 13

Cancer and COVID-19 Experiences at African Cancer Centers: The Silver Lining.

Journal article

Grossheim L. et al, (2021), JCO Glob Oncol, 7, 410 - 415

Designing deep learning studies in cancer diagnostics.

Journal article

Kleppe A. et al, (2021), Nat Rev Cancer, 21, 199 - 211

Deep learning and cancer biomarkers: recognising lead-time bias – Authors' reply

Journal article

Liestøl K. et al, (2021), The Lancet, 397, 194 - 195

Load More